$12.90
1.3211.40%
At close: -
$12.90
0.000.00%
After Hours: 7:34 PM EDT
Ginkgo Bioworks Holdings reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Ginkgo Bioworks Holdings using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-12 | $-1.08 | $-2.71 | 60.2 % |
Q2 | 2024-08-08 | $-4.40 | $-3.20 | -37.5 % |
Q1 | 2024-05-09 | $-3.20 | $-3.20 | 0.00 % |
Q4 | 2024-02-29 | $-4.40 | $-4.00 | -10.0 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-12 | $89.05M | $45.00M | 97.9 % |
Q2 | 2024-08-08 | $56.21M | $43.71M | 28.6 % |
Q1 | 2024-05-09 | $37.94M | $46.04M | -17.6 % |
Q4 | 2024-02-29 | $34.76M | $42.50M | -18.2 % |
Ginkgo Bioworks Holdings (DNA) is scheduled to report earnings on February 27, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
The Actual EPS was $-1.08, which beat the estimate of $-2.71.
The Actual Revenue was $89M, which beat the estimate of $45M.
Browse earnings estimates, EPS, and revenue on all stocks.